Organization: Health Canada
Year: 2024
Month: August
Request Number: A-2024-000125
Request Summary: In respect of the second, newest Abbreviated New Drug Submission (ANDS) for semaglutide (the Second Semaglutide ANDS), please provide a copy of any Screening Acceptance Letter sent by Health Canada to the sponsor of the Second Semaglutide ANDS.
Disposition: Disclosed in part
Number of pages: 1